Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference

NEXT STORY
Turning Point Therapeutics to Host First Quarter Conference Call
PREV STORY
Allakos Announces Positive Interim Results from an Open-Label Extension Study of Antolimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBI Vaccines to Present at the Canaccord Genuity 39th Annual Growth Conference

author_avatar
NASDAQ Market News

Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and clinical AI for the patient-centred management and treatment of chronic disease

                                                         Sensyne Health and the University of Oxford’s Big Data Institute to ...

author_avatar
NASDAQ Market News

Präsentation klinischer Daten zu Zenocutuzumab auf der Jahrestagung 2021 der American Society of Clinical Oncology

author_avatar
NASDAQ Market News